A stable-isotope assay was used to analyze the effectiveness of various perdeuterated short-chain acyl coenzyme A (acyl-CoA) compounds as starter units for straight-and branched-chain fatty acid biosynthesis in cell extracts of Streptomyces collinus. In these extracts perdeuterated isobutyryl-CoA was converted to isopalmitate (a branched-chain fatty acid), while butyryl-CoA was converted to palmitate (a straight-chain fatty acid). These observations are consistent with previous in vivo analyses of fatty acid biosynthesis in S. collinus, which suggested that butyryl-CoA and isobutyryl-CoA function as starter units for palmitate and isopalmitate biosynthesis, respectively. Additionally, in vitro analysis demonstrated that acetyl-CoA can function as a starter unit for palmitate biosynthesis. Palmitate biosynthesis and isopalmitate biosynthesis in these cell extracts were both effectively inhibited by thiolactomycin, a known type II fatty acid synthase inhibitor. In vivo experiments demonstrated that concentrations of thiolactomycin ranging from 0.1 to 0.2 mg/ml produced both a dramatic decrease in the cellular levels of branched-chain fatty acids and a surprising three-to fivefold increase in the cellular levels of the straight-chain fatty acids palmitate and myristate. Additional in vivo incorporation studies with perdeuterated butyrate suggested that, in accord with the in vitro studies, the biosynthesis of the palmitate from butyryl-CoA decreases in the presence of thiolactomycin. In contrast, in vivo incorporation studies with perdeuterated acetate demonstrated that the biosynthesis of palmitate from acetylCoA increases in the presence of thiolactomycin. These observations clearly demonstrate that isobutyryl-CoA is a starter unit for isopalmitate biosynthesis and that either acetyl-CoA or butyryl-CoA can be a starter unit for palmitate biosynthesis in S. collinus. However, the pathway for palmitate biosynthesis from acetyl-CoA is less sensitive to thiolactomycin, and it is suggested that the basis for this difference is in the initiation step.
Despite numerous investigations, a considerable number questions concerning fatty acid biosynthesis in streptomycetes remain. Initial studies suggested that fatty acids in streptomycetes are biosynthesized by a type I fatty acid synthase (FAS) (6, 28) . Such synthases are large, nondissociable, multifunctional complexes which are generally found in yeast and mammalian systems. More recent work has suggested that streptomycetes have a type II FAS; such synthases consist of a series of dissociable enzymes (24, 32) . The type II FAS is more commonly found in bacterial systems and has been extensively characterized in Escherichia coli (17) . The possibility that streptomycetes have both a type I and a type II FAS has not been ruled out (24) .
A number of questions concerning the initiation of fatty acid biosynthesis in streptomycetes have also been raised. Streptomycetes produce predominantly branched-chain fatty acids and a small proportion of straight-chain components (29, 33, 36, 38) . In vivo analysis has indicated that branched-chain fatty acids are biosynthesized by using the amino acid catabolites methylbutyryl coenzyme A (methylbutyryl-CoA) and isobutyryl-CoA as starter units (27, 38) . In vivo experiments have also indicated that butyryl-CoA functions effectively as a starter unit for the biosynthesis of palmitate and myristate, straight-chain fatty acids containing an even number of carbon atoms (27, 38) . One source of butyryl-CoA has been shown to be the rearrangement of the valine-derived catabolite isobutyryl-CoA (38) . However, in the case of Streptomyces collinus, Streptomyces cinnamonensis, and Saccharopolyspora erythraea, in vivo analysis clearly demonstrates that the majority of the palmitate is not formed by using butyryl-CoA thus generated. Accordingly, these systems must have either an additional pathway for butyryl-CoA formation or the potential to initiate straight-chain fatty acid biosynthesis from a starter unit other than butyryl-CoA (38) . Evidence for the former of these suggestions has been the isolation and characterization of a crotonyl-CoA reductase from S. collinus (37) . This enzyme is thought to play a key role in catalyzing the last reductive step in a malonyl-CoA-independent biosynthesis of butyryl-CoA from two acetyl-CoA molecules (37) .
Herein, we report the results of a series of in vivo and in vitro studies with S. collinus, aimed at addressing the initiation of straight-chain fatty acid biosynthesis. These studies have demonstrated that (i) a type II fatty acid synthase (FAS) is involved in both straight-and branched-chain fatty acid biosynthesis; (ii) crotonyl-CoA reductase plays no significant role in providing butyryl-CoA for palmitate biosynthesis; (iii) in addition to a pathway using butyryl-CoA as a starter unit for palmitate biosynthesis, a pathway using a different starter unit (likely acetyl-CoA) operates; and (iv) the FAS inhibitor thiolactomycin has differing effects, likely at the initiation point, on branched-and straight-chain fatty acid biosynthesis.
MATERIALS AND METHODS

Materials.
Deuterated fatty acids and amino acids were purchased from Cambridge Isotopes. Isobutyric acid with six deuterium atoms (D 6 -isobutyric acid) was synthesized from diethyl malonate and deuterated iodomethane by following an established procedure (25) . Materials purchased from Sigma included NADPH, CoA, acyl carrier protein (ACP), and malonyl-CoA. Thiolactomycin was provided by Pfizer Incorporated. CoA thioesters were prepared by the mixed-anhydride method as previously described (26) .
Growth of S. collinus for assays of FAS activity. Seed cultures were prepared by inoculating spores from one slant culture of S. collinus into a 500-ml flask containing 100 ml of a complex medium consisting of 5 g of glucose, 10 g of sucrose, 5 g of tryptone, and 2.5 g of yeast extract in 1 liter of distilled water (pH 7.0). Following incubation at 30°C and 250 rpm for 24 h, 35 ml of the seed culture was transferred to a 2-liter flask containing 400 ml of this complex medium. After incubation for 9 to 12 h at 30°C and 250 rpm, the cells were harvested by centrifugation at 6,000 ϫ g on a Beckman J2-21 centrifuge. The supernatant was discarded, and the cell pellet was washed with buffer A, containing 50 mM potassium phosphate (pH 7.3), 1 mM dithioerythritol, 0.1 mM phenylmethylsulfonyl fluoride, and 10% (vol/vol) glycerol. Following pelleting of the cells by centrifugation and discarding of the supernatant, the cell pellet was resuspended in 7 ml of buffer A and broken by passage through a French pressure cell at 10,000 to 15,000 lb/in 2 . After centrifugation at 30,000 ϫ g, the resulting cell extract was dialyzed for 12 to 15 h against 2 liters of buffer A.
FAS activity with various starter units. The FAS assays for determination of the starter unit for straight-chain fatty acid biosynthesis contained 1 ml of dialyzed cell extract of S. collinus, 0.13 mol of ACP from E. coli, 0.92 mol of NADPH, 1 mol of malonyl-CoA, and a perdeuterated acyl-CoA starter unit in a total volume of 1.4 ml. In one set of experiments, 0.5 mol of D 3 -acetyl-CoA, 0.5 mol of D 7 -butyryl-CoA, and 0.5 mol of D 11 -hexanoyl-CoA were used in separate FAS assays. In a separate set of experiments, 0.5 mol of D 7 -butyrylCoA and 0.5, 2.5, and 5 mol of perdeuterated acetyl-CoA were used in separate FAS assays. An additional FAS assay was conducted with 0.5 mol of D 7 -butyrylCoA, 0.5 mol of D 6 -isobutyryl-CoA, 0.26 mol of ACP from E. coli, 1.84 mol of NADPH, and 2 mol of malonyl-CoA. After 2 h of incubation at 37°C, the FAS assays were terminated by treatment with 0.2 ml of 1 N NaOH at room temperature for 15 min (the fatty acid thioesters are hydrolyzed during this step). Subsequently, 0.4 ml of 6 N HCl was added to precipitate the proteins. Fatty acids were extracted by the addition of 2 ml of hexane to the reaction mixture and were converted to their methyl esters by the addition of diazomethane. The volumes of the samples were reduced to 100 l, and an aliquot (1 l) was analyzed by gas chromatography-mass spectrometry (GC-MS) as previously described (38) . Fatty acid profiles were collected by scanning between 265 and 285 atomic mass units, the region where the molecular ion peaks of palmitate and isopalmitate appear. The results of all the FAS assays for straight-chain fatty acid biosynthesis are expressed as a percentage of the entire palmitate pool extracted from the assay that was made by using the perdeuterated acyl-CoA starter unit. This number was calculated by taking the relative abundances of the molecular ion signals for the deuterated and nondeuterated methyl palmitate from an averaging of all the mass-spectral scans that contained methyl palmitate (38) . The results of FAS assays for branched-chain fatty acid biosynthesis were calculated analogously by using the methyl isopalmitate peak.
Effect of ACP on FAS activity. In a separate set of experiments, 0.13, 0.26, and 0.39 mmol of ACP were used in the assays. The FAS assay incubation and subsequent workup in these were conducted as described above.
Effect of malonyl-CoA on FAS activity. One milliliter of dialyzed cell extract of S. collinus was incubated with 0.5 mol of D 7 -butyryl-CoA, 0.13 mol of ACP from E. coli, 0.92 mol of NADPH, and either 1, 0.5, 0.25, or 0.1 mol of malonyl-CoA in a total volume of 1.4 ml. The FAS assay incubation and subsequent workup were conducted as described above. Samples from each incubation were assayed for production of labeled palmitate (16:0), myristate (14:0), dodecanoate (12:0), and decanoate (10:0) by collecting separate profiles determined by GC-MS analyses scanning between 265 and 285, 240 and 255, 210 and 255, and 185 and 200, respectively.
In vitro effect of thiolactomycin on FAS activity. One milliliter of dialyzed cell extract of S. collinus was preincubated at 37°C for 10 min with either 0, 10, 100, or 250 g of thiolactomycin. The thiolactomycin was prepared as a 10-mg/ml solution in ethanol and was added to each experimental tube and evaporated to dryness prior to addition of the cell extract. Following this preincubation, 0.13 mol of ACP, 0.92 mol of NADPH, 1 mol of malonyl-CoA, and 5 mol of either perdeuterated butyryl-CoA or isobutyryl-CoA were added to each assay to a final volume of 1.4 ml. After 2 h of incubation, fatty acids were analyzed as described above.
Growth of S. collinus for fatty acid analysis. Spores from a slant containing S. collinus were inoculated into a 500-ml flask containing 100 ml of minimal medium which contained 0.5 g of asparagine, 0.5 g of K 2 HPO 4 , 0.2 g of MgSO 4 ⅐ 7H 2 O, and 0.01 g of FeSO 4 ⅐ 7H 2 O in 1 liter of distilled water (pH 7). Glucose was autoclaved separately as a 50% (wt/vol) solution and added, after autoclaving, to a final concentration of 10 g/liter. Following incubation for 3 days at 220 to 250 rpm, 1 ml of seed culture was transferred to a 50-ml flask containing 10 ml of minimal medium. After incubation for 24 h, the cells were harvested by centrifugation at 3,000 ϫ g, and the supernatant was discarded. Following a wash with distilled water, the cells were pelleted by centrifugation. The cells were then treated with 1.2 N sodium hydroxide solution at 100°C for 30 min as previously described (38) . A lauric acid standard (200 l of a 0.34 mM lauric acid solution) was added, and fatty acids were converted to their methyl esters, extracted, and analyzed by GC-MS, as described previously (38) .
In vivo effect of thiolactomycin on fatty acid biosynthesis. The effect of thiolactomycin on fatty acid biosynthesis in vivo was determined by carrying out the following sets of experiments. Parallel 10-ml fermentations of S. collinus in the presence and absence of thiolactomycin (1 mg) were grown in (i) minimal medium alone, (ii) minimal medium with D 3 -acetate (10 mM), (iii) minimal medium with D 6 -butyrate (4.3 mM), (iv) minimal medium with both D 3 -acetate (10 mM) and D 6 -butyrate (4.3 mM), and (v) minimal medium with D 6 -isobutyrate (4.3 mM). The labeled fatty acids were prepared in distilled water, adjusted to pH 7.0, filter sterilized, and added to the culture medium at the time of inoculation. Thiolactomycin was prepared as a 10-mg/ml stock solution in ethanol and added to the culture at the time of inoculation. Following 24 h of cultivation the cellular fatty acids were analyzed as described previously (38) .
The fatty acid quantities were estimated by integrating the total ion chromatograms from the fatty acid analyses and comparing the area of each fatty acid peak with the area for the lauric acid standard (control experiments clearly demonstrated that no detectable quantities of endogenous lauric acid were present in the cells).
Determination of the percent labeling of each peak from a deuterated starter unit then allowed the quantities of the labeled and unlabeled fatty acids to be calculated. The determination of the percent labeling of the isopalmitate pool from D 6 -isobutyrate was based on a comparison of the relative intensities of the molecular ions at 270 (unlabeled methyl isopalmitate) and 276 (methyl isopalmitate containing six deuterium atoms) in the manner described previously (38) . Determination of the percent labeling of the palmitate pool from D 7 -butyrate was calculated in an analogous fashion by using the relative intensities of molecular ions at 270 (unlabeled methyl palmitate) and 276 and 277 (methyl palmitate containing six and seven deuterium atoms, respectively). Determination of the percent labeling of the palmitate pool from D 3 -acetate was based on the relative intensities of molecular ions at 273 (methyl palmitate with three deuterium atoms) and 270, after correction for natural abundance of 13 C and incorporation of deuterated malonate. Determination of the percent labeling at each of the seven malonate-derived positions in palmitate with one deuterium atom from D 3 -acetate was calculated based on the ratio of the molecular ion at 271 (methyl palmitate with one deuterium atom) to the molecular ion at 270, after correction for natural abundance of 13 C (38) . In experiments where labeling of the palmitate pool from both D 3 -acetate and D 6 -butyrate occurred, the percent labeling from each starter unit was based on the relative intensities of the molecular ions at 276, 273 (after the appropriate corrections), and 270.
This estimation of total amount of each fatty acid (labeled and unlabeled) is based on the assumptions that all the long-chain fatty acids extract into hexaneether (50:50) with the same efficiency and that equal mass quantities of fatty acids give rise to equal-sized peaks in a total ion chromatogram GC-MS analysis. Errors due to these assumptions occur in each experiment set (with and without thiolactomycin) and so do not alter the magnitude of an effect of thiolactomycin on fatty acid levels relative to the lauric acid standard (although the reported nanomole quantity is subject to error). A control experiment in which an aqueous solution containing equal quantities of lauric acid, myristic acid, palmitic acid, and isopalmitic acid were converted to their methyl esters, extracted, and analyzed by GC-MS indicated that the errors from these assumptions are small (less than 10%).
In vivo analysis of fatty acid biosynthesis in an S. collinus ccr mutant. An S. collinus ccr mutant (9) was grown in minimal medium (10 ml) containing either no perdeuterated starter units or 200 mM valine for 24 h in the manner described above. The fatty acid profile was then generated and analyzed in the manner described previously (38) .
RESULTS
Assay development. FAS assays have previously been employed for cell extracts of streptomycetes and other bacteria which produce predominantly branched-chain fatty acids. These methods typically utilize either a radioactive acyl-CoA starter unit or a malonyl-CoA extender and quantitate the radioactivity that extracts into an organic phase (8, 16) . Although sensitive, such assays do not permit the unambiguous determination of intact incorporation of starter units into the product. Accordingly, a stable-isotope-based GC-MS assay was developed. This method, based on an in vivo method described for analysis of starter unit utilization in fatty acid biosynthesis (38) , allows direct measurement of the intact incorporation of the starter units into the specific fatty acids in a cell extract. An additional advantage of the assay is that it allows the carbon chain length of the product to be determined.
As shown in Fig. 1 cell extract in the absence of either NADPH, malonyl-CoA, or a perdeuterated starter unit. In contrast, incubation in the presence of ACP, NADPH, malonyl-CoA, and perdeuterated butyryl-CoA resulted in the production of labeled methyl palmitate containing seven deuterium atoms. In the FAS assay the labeled palmitate which formed in the cell extract was readily distinguishable from the unlabeled endogenous palmitate by a shorter retention time in the gas chromatogram and by the mass-spectral analysis (a molecular ion at 277 versus 270). The unlabeled methyl palmitate and isopalmitate were used as internal standards to compare FAS activities under various conditions. A FAS assay with a crude cell extract has obvious limitations. Since the enzyme preparation is not pure, numerous competing reactions or degradative enzymes may utilize the substrates and change their apparent concentrations. Such a rationale explains the variation in the magnitude of percent labeling of the individual fatty acid pools between sets of experiments. Accordingly, control assays were conducted for each set of experiments. The relative amounts of unlabeled isopalmitate and palmitate also varied between experiments, possibly due to changes in the dialysis, solvent extraction, and culture conditions. Nonetheless, the trends and observations that are reported were absolutely consistent between the sets of experiments.
Requirement of FAS activity for malonyl-CoA. In one set of experiments, 38, 25, 26, and 12% of the palmitate pool was labeled with deuterium atoms when the assays were conducted with 1, 0.5, 0.25, and 0.1 mol of malonyl-CoA, respectively. In the same experiment, 7 and 5.7% of the myristate pool was labeled in the incubations with 1 and 0.5 mol of malonylCoA, respectively (no detectable level of labeled myristate was observed in the other two assays). Interestingly, only 16-and 14-carbon chain fatty acid products were detected in assays using a butyryl-CoA starter unit, regardless of the ratio of butyryl-CoA to malonyl-CoA. A previous analysis of fatty acid biosynthesis in Saccharopolyspora erythraea using an isobutyrylCoA starter unit showed that under the assay conditions the predominant product appeared to be a terminally branched eight-carbon fatty acid (8) .
Requirement of FAS activity for an ACP. Addition of the E. coli ACP resulted in a marked increase in the production of labeled palmitate from perdeuterated butyryl-CoA. In one experiment, 1, 2.6, and 5.4% of the overall palmitate pool was labeled when the assays were conducted with 0, 0.13, and 0.26 mol of ACP, respectively. In a separate experiment, 2.2, 4.1, and 6.7% of the overall palmitate pool was isotopically enriched when the assays were conducted in the presence of 0.13, 0.26, and 0.39 mol of ACP, respectively.
Isobutyryl-CoA as a starter unit for branched-chain fatty acid biosynthesis. Incubation of the cell extract in the presence of 0.5 mol of isobutyryl-CoA and 0.5 mol of butyryl-CoA resulted in the production of similar levels of labeled isopalmitate (as evidenced by the shoulder peak, adjacent to the unlabeled isopalmitate peak, which contained a molecular ion at 276) and palmitate (Fig. 1) . These results suggest that under the assay conditions, butyryl-CoA and isobutyryl-CoA are used comparably for fatty acid biosynthesis. Isobutyryl-CoA has previously been implicated as a starter unit for branched-chain fatty acid biosynthesis by in vivo analyses with S. collinus and Streptomyces avermitilis (27, 38) and by in vitro analysis with Saccharopolyspora erythraea (8) .
Acetyl-CoA, butyryl-CoA, and hexanoyl-CoA as starter units for straight-chain fatty acid biosynthesis. To determine the preferred starter unit for straight-chain fatty acid biosynthesis in S. collinus, in vitro FAS assays were conducted with acetylCoA, butyryl-CoA, and hexanoyl-CoA as starter units. Addition of perdeuterated butyryl-CoA results in a greater percent (12% Ϯ 1%) labeling of the palmitate pool with deuterium than either acetyl-CoA (none detectable) or hexanoyl-CoA (4% Ϯ 0.4%), suggesting that it may be the preferred starter unit for straight-chain fatty acid biosynthesis in S. collinus. Hexanoyl-CoA was both utilized directly as a starter unit for straight-chain fatty acid biosynthesis and degraded during the assay to butyryl-CoA, which was subsequently incorporated into the palmitate pool (1.4% of the palmitate pool had a molecular ion at 277, corresponding to Mϩ7).
These results suggest that acetyl-CoA, at a concentration of 0.64 mM, is ineffective as a starter unit for straight-chain fatty acid biosynthesis. Increased concentrations of acetyl-CoA clearly permit it to function as a starter unit. However, at the same concentrations (0.37 mM), butyryl-CoA functions 10 times more effectively than acetyl-CoA, as measured by percent labeling of the palmitate pool (26.8 versus 2.5%). Even at high concentrations (1.85 and 3.7 mM), acetyl-CoA does not appear to function as effectively as butyryl-CoA as a starter Labeled methyl palmitate (C) was eluted slightly earlier than methyl palmitate from the GC column and exhibited a molecular ion and fragmentation pattern in the mass-spectral analyses consistent with its containing seven deuterium atoms. (Bottom) Analysis for a FAS assay with D 6 -isobutyryl-CoA and D 7 -butyryl-CoA. Labeled methyl isopalmitate (D) was eluted slightly earlier than methyl isopalmitate from the GC column and exhibited a molecular ion and fragmentation pattern in the mass-spectral analyses consistent with its containing six deuterium atoms.
unit (values of 11.7 and 7.0%, respectively, for labeling of the palmitate pool).
In vitro inhibition of fatty acid biosynthesis by thiolactomycin. Thiolactomycin (10 to 250 g/ml), a known type II FAS inhibitor (10, 11, 20, 21, 31, 35) , inhibited palmitate biosynthesis from D 7 -butyryl-CoA (Fig. 2) . A thiolactomycin concentration of 50 g/ml (240 M) was estimated to result in a 50% inhibition of synthase activity under the conditions of this experiment. A similar inhibition of isopalmitate biosynthesis from D 6 -isobutyryl-CoA by thiolactomycin was observed.
In vivo effect of thiolactomycin on fatty acid biosynthesis. The fatty acid profile of S. collinus cultures grown in the presence of 0.1 mg of thiolactomycin per ml reveals a 5-to 10-fold decrease in the quantities of the branched-chain fatty acids and the odd-numbered straight-chain fatty acid pentadecanoate and a 2-to 4-fold increase in the quantities of straight-chain saturated and unsaturated even-numbered fatty acids ( Fig. 3 ; Table 1 ). These substantial changes in fatty acid composition were highly reproducible. The overall fatty acid production and bacterial growth were not dramatically affected by thiolactomycin at this concentration. A comparison of the total fatty acids from the two experiments indicated that a small (20%) decrease was observed for cells grown in the presence of thiolactomycin. A Bradford assay (2) of bacterial cells from the two experiments revealed an approximate decrease of 10% in the protein concentrations. A higher concentration of thiolactomycin (0.4 mg/ml) did, however, inhibit growth of S. collinus. Less dramatic changes in the fatty acid profile were observed when a lower concentration of thiolactomycin (0.05 mg/ml) was used.
Effect of thiolactomycin on the incorporation of butyrate, acetate, and isobutyrate into the palmitate and isopalmitate pool. Addition of thiolactomycin to growing cultures of S. collinus was observed to produce differing effects on the utilization of exogenously supplied starter units for straight-and branched-chain fatty acids ( Fig. 4; Table 2 ). In experiments with D 6 -isobutyrate, addition of thiolactomycin resulted in a decrease in the production of both unlabeled isopalmitate and labeled isopalmitate derived from a D 6 -isobutyryl-CoA starter unit. This result is consistent with an inhibition of isopalmitate biosynthesis from a pool of labeled and unlabeled isobutyrylCoA. In experiments with D 3 -acetate, addition of thiolactomycin resulted in an increase in the amounts of both unlabeled palmitate and labeled palmitate made from D 3 -acetate. This result suggests that the biosynthesis of palmitate from an acetyl-CoA pool is not inhibited by low levels of thiolactomycin. In contrast to the results of the D 3 -acetate experiments, the experiments with D 6 -butyrate demonstrated that addition of thiolactomycin led to a decrease in the levels of labeled palmitate made from D 6 -butyryl-CoA (although the overall amount of palmitate once again increased). These two sets of experiments suggest that thiolactomycin inhibits palmitate biosynthesis from butyryl-CoA but not acetyl-CoA. Two additional observations provide support for these suggestions. In the experiments with D 6 -butyrate, the addition of thiolactomycin resulted in an increase in the amount of palmitate made from a D 3 -acetyl-CoA starter unit (presumably formed from the ␤-oxidation of D 6 -butyryl-CoA). In experiments using D 3 -acetate and D 6 -butyrate together, the addition of thiolactomycin resulted in an increase in the levels of both unlabeled palmitate and palmitate made from D 3 -acetyl-CoA but a decrease in the levels of palmitate made from D 6 -butyryl-CoA.
In the experiments using D 3 -acetate, the amount of the palmitate pool labeled by using a D 3 -acetyl-CoA starter unit ranged from 6 to 28% (Fig. 4) . Substantially lower levels of incorporation of deuterated malonyl-CoA into palmitate and other fatty acids were observed (3 to 5% labeling at each of the malonate-derived positions with one deuterium atom). This labeling likely reflects the generation of D 2 -malonyl-CoA from D 3 -acetyl-CoA and a subsequent incorporation into fatty acids with the loss of one additional deuterium atom during the dehydration step of fatty acid biosynthesis. Lower levels of incorporation as malonate than as acetate likely arise from a washout of deuterium label from either malonyl-CoA or the ␤-ketoacyl-ACP fatty acid intermediate (30) . 
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Effect of thiolactomycin on the fatty acid profile of the S. collinus ccr mutant. It has previously been suggested that crotonyl-CoA reductase may play a significant role in providing butyryl-CoA from straight-chain fatty acid biosynthesis in S. collinus. We have investigated this hypothesis by generating a strain of S. collinus in which the crotonyl-CoA reductase gene (ccr) was disrupted. This ccr mutant and the wild-type strain of S. collinus, grown under identical conditions, exhibited indistinguishable fatty acid profiles. The major straight-chain fatty acid, palmitate, represented 18% Ϯ 1% of the total fatty acid pool for both the wild type and the ccr mutant. Addition of perdeuterated valine to the fermentation broth resulted in an 83% labeling of the isopalmitate pool with seven deuterium atoms and a 14% labeling of the palmitate pool with deuterium in both strains.
DISCUSSION
A type II FAS for straight-and branched-chain fatty acid biosynthesis. Initial reports of fatty acid biosynthesis in Streptomyces coelicolor and Saccharopolyspora erythraea (formerly Streptomyces erythraeus) indicated a type I FAS (6, 28) . More recent enzymatic and genetic analyses of fatty acid biosynthesis in S. coelicolor, Streptomyces glaucescens, S. collinus, and Saccharopolyspora erythraea have indicated that these systems have a type II FAS (23, 24, 32, 38) . The possibility of both a type I and a type II FAS in streptomycetes has yet to be definitively ruled out (24) but appears to be inconsistent with reports that mutants of either S. glaucescens or S. coelicolor cannot be obtained with a disruption in the putative type II fatty acid biosynthetic genes clusters (23, 32) . The clear demonstration that straight-chain fatty acid biosynthesis in dialyzed cell extracts of S. collinus is greatly stimulated by addition of an ACP suggests a type II FAS is at least the major straight-chain FAS activity in these extracts. It has previously been shown that branched-chain fatty acid biosynthesis from isobutyryl-CoA in Saccharopolyspora erythraea was similarly dependent upon addition of the E. coli ACP (8) . A background rate of fatty acid biosynthesis observed in both S. collinus and Saccharopolyspora erythraea (8) a Fatty acids were obtained from a 10-ml fermentation and were estimated based on comparison with a lauric acid standard and the caveat that all the fatty acids extract into hexane or ether with the same efficiency. These data are from one experiment. Values in parentheses are percentages of the values obtained in control experiments. In more than 20 additional experiments, an increase in the ratio of straight-chain to branched-chain fatty acids was always observed in the presence of thiolactomycin (the extent of this change was dependent upon experimental conditions, such as inoculum size). Thiolactomycin was added at the time of inoculation to a final concentration of 0.1 mg/ml. The levels of branched-chain C 17 fatty acids produced in control experiments were also observed to decrease in the experiments with thiolactomycin (data not shown). Abbreviations: bC 14 , isomyristate; bC 15 , iso-and anteisopentadecanoate; bC 16 , isopalmitate; C 14 , myristate; C 15 , pentadecanoate; C 16:1 , hexadecenoate (an isomer of palmitoleate); C 16 , palmitate. in vitro and in vivo inhibition of both branched-and straightchain fatty acid biosynthesis by thiolactomycin, a known type II FAS inhibitor (10, 11, 20, 21, 31, 35) . While this in vitro inhibition (50 g/ml) is substantially less than that reported for E. coli (0.4 g/ml), it contrasts with reports that Bacillus subtilis (also a producer of branched-and straight-chain fatty acids) is not significantly inhibited by thiolactomycin at concentrations as high as 200 g/ml (1). Furthermore, it has been shown that branched-chain fatty acid biosynthesis in a number of Bacillus species is largely insensitive to thiolactomycin (1).
Acetyl-CoA and butyryl-CoA function as starter units for palmitate biosynthesis. In the majority of FASs studied, straight-chain fatty acids are biosynthesized by elongation of an acetyl-CoA starter unit (16) . However, in vivo analysis has suggested that in some systems which generate a mixture of branched-and straight-chain fatty acids, butyryl-CoA can function more effectively than acetyl-CoA as a primer for straightchain fatty acid biosynthesis (16) . Previous in vivo analysis of S. collinus has indicated that butyryl-CoA also functions efficiently as a starter unit for straight-chain fatty acid biosynthesis (38) . Consistent with these conclusions are in vitro studies of S. collinus which demonstrate that at the same concentration butyryl-CoA is a considerably more effective primer for straight-chain fatty acid biosynthesis than either acetyl-CoA or hexanoyl-CoA. However, acetyl-CoA is a common intermediate in cellular metabolism and likely exists at a higher concentration than either butyryl-CoA or hexanoyl-CoA. The present work has demonstrated that acetyl-CoA used at substantially higher concentrations than butyryl-CoA can function effectively as a starter unit for straight-chain fatty acid biosynthesis in an S. collinus cell extract. This observation indicates that in vivo, acetyl-CoA may play a significant role in straight-chain fatty acid biosynthesis. Supporting evidence for this conclusion was obtained from the in vivo studies, which clearly showed that D 3 -acetate was utilized as a starter unit for palmitate biosynthesis.
Analysis of a ccr mutant of S. collinus provides additional support for a significant role of acetyl-CoA in straight-chain fatty acid biosynthesis. Previously it has been shown that in S. collinus grown in the presence of 250 mM valine, approximately 14% of the total cellular palmitate was generated by using butyryl-CoA generated from the valine catabolite isobutyryl-CoA. Two possible interpretations of this observation are that (i) additional pathways provide butyryl-CoA for straightchain fatty acid biosynthesis, and (ii) the majority of straightchain fatty acids are not made by using butyryl-CoA. Evidence for the former of these has been the isolation and characterization of a crotonyl-CoA reductase from S. collinus involved in catalyzing the last step in the biosynthesis of butyryl-CoA from two acetyl-CoA molecules. If crotonyl-CoA reductase plays a role in providing butyryl-CoA for fatty acid biosynthesis, an S. collinus ccr mutant would be expected to either (i) produce fewer straight-chain fatty acids or (ii) produce a greater proportion of the straight-chain fatty acids by using butyryl-CoA derived from the valine catabolism pathway. A ccr mutant of S. collinus, however, exhibited neither of these phenotypes; the percentage of palmitate generated in both the wild type and the ccr mutant of S. collinus was unchanged, and a labeling study with perdeuterated valine suggested that in both cases approximately 84% of the palmitate was generated without using the valine-derived butyryl-CoA. Accordingly, the majority of palmitate in S. collinus must be made either by using butyryl-CoA derived from a hitherto-unknown pathway or, as suggested above, an alternative starter unit, such as acetyl-CoA. Additional support for the role of acetyl-CoA in initiation of straight-chain fatty acid biosynthesis was provided by in vivo studies with thiolactomycin.
Thiolactomycin has differing effects in vivo on branchedchain and straight-chain fatty acid biosynthesis. Thiolactomycin in vivo appeared to inhibit branched-chain fatty acid biosynthesis and activate straight-chain fatty acid biosynthesis. The increase in saturated straight-chain fatty acids was accompanied by an increase in unsaturated straight-chain fatty acids. As the overall levels of fatty acids decreased slightly, it appears that thiolactomycin redirected an inhibited fatty acid synthetic process. A change from branched-chain to straight-chain fatty acids has been observed with an S. avermitilis mutant genetically blocked in the formation of isobutyryl-CoA and methylbutyryl-CoA (and therefore unable to produce branched-chain fatty acids) and with S. cinnamonensis grown on a synthetic medium with increasing concentrations of sodium chloride (the changes in the fatty acid profiles in this case were considerably less than reported herein) (5, 18, 22) . In all of these cases the bacteria appear to compensate for the loss of the branched-chain anteiso-C 15 acids, which are important for reg- (15), by producing unsaturated straight-chain fatty acids. The thiolactomycin-dependent decrease in the levels of isopalmitate and other branched-chain fatty acids was matched by an analogous decrease in the levels of labeled isopalmitate obtained when D 6 -isobutyrate was included in the fermentation broth. This in vitro data indicates that thiolactomycin inhibits branched-chain fatty acid biosynthesis from isobutyrylCoA (in agreement with in vitro data). A decrease in the levels of labeled palmitate obtained from D 7 -butyrate also indicates that in vivo, thiolactomycin inhibits straight-chain fatty acid biosynthesis from butyryl-CoA (in agreement with in vitro data). Despite this inhibition, the levels of some straight-chain saturated and unsaturated fatty acids actually increase in the presence of thiolactomycin. This observation suggests that an additional pathway or initiation point for straight-chain fatty acid biosynthesis operates in S. collinus. This process should be less sensitive to thiolactomycin and might, as suggested above, use acetyl-CoA rather than butyryl-CoA as a starter unit. Compelling evidence for this suggestion was the observation that the levels of labeled palmitate made by using a perdeuterated acetate starter unit increased in the presence of thiolactomycin (in sharp contrast to the incorporation results obtained with labeled butyrate and isobutyrate).
Differential pathways for initiation of straight-chain and branched-chain fatty acid biosynthesis in S. collinus. One interpretation of the data presented herein is that S. collinus has both a thiolactomycin-sensitive type II FAS (responsible for branched-chain fatty acid biosynthesis and straight-chain fatty acid biosynthesis) and a thiolactomycin-insensitive type I FAS (responsible for palmitate biosynthesis from acetyl-CoA). Thiolactomycin is known to be selective against type II FASs (10, 11, 20, 21, 31, 35) . Although this possibility cannot be excluded, there is no firm evidence of a type I FAS in any streptomycete. Alternatively, the results may indicate that thiolactomycin simply exposed a difference in the initiation of fatty acid biosynthesis from acetyl-CoA and butyryl-CoA, isobutyryl-CoA, or even methylbutyryl-CoA. Two different pathways for initiation of fatty acid biosynthesis have been proposed for E. coli and plants (7, 17) , systems which produce exclusively straight-chain fatty acids. In one of these pathways, 3-ketoacyl synthase III (KASIII) catalyzes the condensation of acetylCoA with malonyl-ACP to form ␤-ketobutyryl-ACP (13, 17) . In the second pathway, acetyl-CoA is first transacylated to form acetyl-ACP and then condensed with malonyl-ACP by using 3-ketoacyl synthase I (KASI) (17) . It is unclear if the transacylation reaction is carried out exclusively by KASIII (which has been shown to have this activity) (4, 34) or by a separate acyl-CoA/ACP transacylase activity (ACAT) (7, 17) . Similar roles can be considered for KASIII and an acyl-CoA/ ACP transacylase activity in the initiation of fatty acid biosynthesis from the various starter units in S. collinus (Fig. 5) . The thiolactomycin results presented herein can be rationalized if the initiation step with butyryl-CoA and isobutyryl-CoA (and presumably methylbutyryl-CoA and propionyl-CoA) is both different from that utilizing acetyl-CoA and more sensitive to thiolactomycin than any other step in the fatty acid biosynthetic process (thiolactomycin is known to have differing effects on the various enzymes involved in fatty acid biosynthesis in plants and E. coli [12, 14, 19, 35] ). To date, however, there is no information regarding the individual enzymes involved in initiation of fatty acid biosynthesis in streptomycetes. However, it has been suggested that acetyl-ACP may function as a starter unit for straight-chain fatty acid biosynthesis in streptomycetes (33) . While there is no direct data supporting this suggestion, it has been shown that in B. subtilis (which also produces predominantly branched-chain fatty acids) acetyl-ACP, but not acetyl-CoA, is an excellent primer for straight-chain fatty acid biosynthesis (3, 15) . In addition, the recent cloning of the putative fatty acid biosynthetic gene clusters of S. coelicolor and S. glaucescens has revealed genes which would encode proteins with high homology to E. coli KASIII (23, 32) . It should now be possible to investigate both the role of these putative streptomycete KASIII enzymes in the initiation of straight-and branched-chain fatty acid biosynthesis and the basis for the unusual in vivo effect of thiolactomycin on the fatty acid profile of S. collinus.
